|
|
结直肠癌筛查方法的研究进展
|
Abstract:
结直肠癌(colorectal cancer, CRC)是全球第三大常见癌症，与其他癌症不同，结直肠癌可以通过筛查来预防，如果早期诊断和治疗，可能具有相对良好的预后。目前筛查仍然是降低CRC发病率和死亡率的最好的方法。本文旨在对于结直肠癌查方法作一综述。
Colorectal cancer (CRC) is the third most common cancer in the world. Unlike other cancers, colo-rectal cancer can be prevented through screening and may have a relatively favorable prognosis if diagnosed and treated early. Screening remains the best way to reduce CRC morbidity and mortali-ty. The purpose of this paper is to review the screening methods of colorectal cancer.
| [1] | Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660 |
| [2] | 王纯, 陈东风, 魏艳玲. 肠道菌群对结直肠癌发生、发展和诊疗影响的研究进展[J]. 胃肠病学, 2019, 24(1): 62-64. |
| [3] | Arnold, M., Sierra, M.S., Laversanne, M., et al. (2017) Global Pat-terns and Trends in Colorectal Cancer Incidence and Mortality. Gut, 66, 683-691. https://doi.org/10.1136/gutjnl-2015-310912 |
| [4] | 《“健康中国2030”规划纲要》[J]. 中国肿瘤, 2019, 28(10): 724. |
| [5] | Zhang, M., Zhao, L., Zhang, Y., et al. (2022) Colorectal Cancer Screening with High Risk-Factor Question-naire and Fecal Immunochemical Tests among 5,947,986 Asymptomatic Population: A Population-Based Study. Fron-tiers in Oncology, 12, Article ID: 893183. https://doi.org/10.3389/fonc.2022.893183 |
| [6] | Yeoh, K.G., Ho, K.Y., Chiu, H.M., et al. (2011) The Asia-Pacific Colorectal Screening Score: A Validated Tool That Stratifies Risk for Colo-rectal Advanced Neoplasia in Asymptomatic Asian Subjects. Gut, 60, 1236-1241.
https://doi.org/10.1136/gut.2010.221168 |
| [7] | 翟爱军, 翟惠虹, 陈洪, 等. APCS评分系统与问卷调查在体检人群结直肠癌机会性筛查中效果的比较[J]. 中华保健医学杂志, 2018, 20(3): 217-219. |
| [8] | Luu, X.Q., Lee, K., Kim, J., et al. (2021) The Classification Capability of the Asia Pacific Colorectal Screening Score in Korea: An Analysis of the Cancer Screenee Cohort. Epidemiology and Health, 43, e2021069.
https://doi.org/10.4178/epih.e2021069 |
| [9] | 康倩, 李娜, 王瑞芳, 等. 亚太结直肠癌筛查评分联合定量法便潜血在结直肠肿瘤筛查的初步应用[J]. 中华医学杂志, 2021, 101(46): 3825-3828. |
| [10] | U, H.V. and Burke, C.A. (2009) Advances in Colorectal Cancer Screening. Current Gastroenterology Reports, 11, 406-412. https://doi.org/10.1007/s11894-009-0061-z |
| [11] | Chubak, J., Bogart, A., Fuller, S., et al. (2013) Uptake and Posi-tive Predictive Value of Fecal Occult Blood Tests: A Randomized Controlled Trial. Preventive Medicine, 57, 671-678. https://doi.org/10.1016/j.ypmed.2013.08.032 |
| [12] | Wang, J., Liu, S., Wang, H., et al. (2020) Robust Performance of a Novel Stool DNA Test of Methylated SDC2 for Colorectal Cancer Detection: A Multicenter Clinical Study. Clinical Epigenetics, 12, 162.
https://doi.org/10.1186/s13148-020-00954-x |
| [13] | Bosch, L.J., Melotte, V., Mongera, S., et al. (2019) Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. American Journal of Gas-troenterology, 114, 1909-1918.
https://doi.org/10.14309/ajg.0000000000000445 |
| [14] | Price, M., Lester, L., Chiniwala, R., et al. (2017) Multitarget Stool DNA Tests Increases Colorectal Cancer Screening among Previously Noncompliant Medicare Patients. World Journal of Gastroenterology, 23, 464-471.
https://doi.org/10.3748/wjg.v23.i3.464 |
| [15] | Ladabaum, U. and Mannalithara, A. (2016) Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology, 151, 427-439.
https://doi.org/10.1053/j.gastro.2016.06.003 |
| [16] | Reventive Services Task Force, Davidson, K.W., Barry, M.J., et al. (2021) Screening for Colorectal Cancer: US Pre？ ventive Services Task Force Recommendation Statement. JAMA, 325, 1965-1977.
https://doi.org/10.1001/jama.2021.6238 |
| [17] | 贺子轩, 沈振, 顾伦, 等. 多靶点粪便DNA检测技术在结直肠癌筛查中的应用价值研究进展[J]. 结直肠肛门外科, 2021, 27(6): 542-546. |
| [18] | Bocchetti, M., Ferraro, M.G., Ricciardiello, F., et al. (2021) The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer. Interna-tional Journal of Molecular Sciences, 22, 3967-3981.
https://doi.org/10.3390/ijms22083967 |
| [19] | Chen, H., Xu, Z. and Liu, D. (2019) Small Non-Coding RNA and Col-orectal Cancer. Journal of Cellular and Molecular Medicine, 23, 3050-3057. https://doi.org/10.1111/jcmm.14209 |
| [20] | Keenan, J.I. and Frizelle, F.A. (2022) Biomarkers to Detect Early-Stage Colorectal Cancer. Biomedicines, 10, 255.
https://doi.org/10.3390/biomedicines10020255 |
| [21] | Tjalsma, H., Boleij, A., Marchesi, J.R., et al. (2012) A Bacteri-al Driver-Passenger Model for Colorectal Cancer: Beyond the Usual Suspects. Nature Reviews Microbiology, 10, 575-582. https://doi.org/10.1038/nrmicro2819 |
| [22] | Sears, C.L. and Garrett, W.S. (2014) Microbes, Microbiota, and Colon Cancer. Cell Host & Microbe, 15, 317-328.
https://doi.org/10.1016/j.chom.2014.02.007 |
| [23] | Avril, M. and DePaolo, R.W. (2021) “Driver-Passenger” Bacteria and Their Metabolites in the Pathogenesis of Colorectal Cancer. Gut Microbes, 13, Article ID: 1941710. https://doi.org/10.1080/19490976.2021.1941710 |
| [24] | Huang, X., Lan, Y., Li, E., et al. (2021) Diagnostic Values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in Patients with Colorectal Cancer. Journal of In-ternational Medical Research, 49.
https://doi.org/10.1177/03000605211012570 |
| [25] | Chen, B., Xia, Z., Deng, Y.N., et al. (2019) Emerging mi-croRNA Biomarkers for Colorectal Cancer Diagnosis and Prognosis. Open Biology, 9, Article ID: 180212. https://doi.org/10.1098/rsob.180212 |
| [26] | Sefrioui, D., Beaussire, L., Gillibert, A., et al. (2021) CEA, CA19-9, Circulating DNA and Circulating Tumour Cell Kinetics in Patients Treated for Metastatic Colorectal Cancer (mCRC). British Journal of Cancer, 125, 725-733.
https://doi.org/10.1038/s41416-021-01431-9 |
| [27] | Qian, X., Wang, H., Ren, Z., et al. (2021) The Value of NLR, FIB, CEA and CA19-9 in Colorectal Cancer. Chinese Journal of Preventive Medicine, 55, 499-505. (In Chi-nese) |
| [28] | Zhao, X.Y, et al. (2021) Diagnostic Performance of microRNAs in Testicular Germ Cell Tumors: A Sys-tematic Review and Meta-Analysis. Aging (Albany NY), 13, 19657-19677. https://doi.org/10.18632/aging.203376 |
| [29] | Tsai, W.-S., Nimgaonkar, A., Segurado, O., et al. (2018) Prospective Clinical Study of Circulating Tumor Cells for Colorectal Cancer Screening. Clinical Oncology, 36, 556. https://doi.org/10.1200/JCO.2018.36.4_suppl.556 |
| [30] | 靳博, 向征. 循环肿瘤细胞在结直肠癌中的应用及研究进展[J]. 现代医药卫生, 2021, 37(14): 2416-2420. |
| [31] | 刘莉, 蒋萍, 戈伟. ctDNA在结直肠癌诊疗中的应用[J]. 中国医药导报, 2021, 18(21): 33-37. |
| [32] | 周鑫亚, 燕书明, 张萌萌, 等. 消化系统肿瘤液体活检研究进展[J]. 胃肠病学和肝病学杂志, 2021, 30(9): 1060-1067. |
| [33] | Chen, Y., Wang, Z., Zhao, G., et al. (2019) Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test. Disease Markers, 2019, Article ID: 5232780.
https://doi.org/10.1155/2019/5232780 |
| [34] | Zhao, G., Li, H., Yang, Z., et al. (2019) Multiplex Methylated DNA Testing in Plasma with High Sensitivity and Specificity for Colorectal Cancer Screening. Cancer Medicine, 8, 5619-5628. https://doi.org/10.1002/cam4.2475 |
| [35] | Ma, Z.Y., Law, W.L., Ng, E.K.O., et al. (2019) Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients with Colorectal Cancer after Surgery. Scientific Reports, 9, Article No. 10326.
https://doi.org/10.1038/s41598-019-46876-4 |
| [36] | He, N., Song, L., Kang, Q., et al. (2018) The Pathological Fea-tures of Colorectal Cancer Determine the Detection Performance on Blood ctDNA. Technology in Cancer Research & Treatment, 17.
https://doi.org/10.1177/1533033818791794 |
| [37] | Quintero, E., Castells, A., Bujanda, L., et al. (2012) Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. The New England Journal of Medicine, 366, 697-706. https://doi.org/10.1056/NEJMoa1108895 |
| [38] | Spadaccini, M., Frazzoni, L., Vanella, G., et al. (2020) Ef-ficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 18, 1454-1465.e14. https://doi.org/10.1016/j.cgh.2019.10.044 |
| [39] | Mitsala, A., Tsalikidis, C., Pitiakoudis, M., et al. (2021) Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era. Current Oncology, 28, 1581-1607. https://doi.org/10.3390/curroncol28030149 |
| [40] | Spada, C., Pasha, S.F., Gross, S.A., et al. (2016) Accuracy of First- and Second-Generation Colon Capsules in Endoscopic Detection of Colorectal Polyps: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 14, 1533-1543.e8. https://doi.org/10.1016/j.cgh.2016.04.038 |
| [41] | Pecere, S., Senore, C., Hassan, C., et al. (2020) Accuracy of Colon Capsule Endoscopy for Advanced Neoplasia. Gastrointestinal Endoscopy, 91, 406-414. https://doi.org/10.1016/j.gie.2019.09.041 |
| [42] | Stoop, E.M., de Haan, M.C., de Wijkerslooth, T.R., et al. (2012) Participation and Yield of Colonoscopy versus Non-Cathartic CT Colonography in Population-Based Screening for Col-orectal Cancer: A Randomised Controlled Trial. The Lancet Oncology, 13, 55-64. https://doi.org/10.1016/S1470-2045(11)70283-2 |
| [43] | González-Suárez, B., Pagés, M., Araujo, I.K., et al. (2020) Colon Capsule Endoscopy versus CT Colonography in FIT-Positive Colorectal Cancer Screening Subjects: A Prospec-tive Randomised Trial—The VICOCA Study. BMC Medicine, 18, 255. https://doi.org/10.1186/s12916-020-01717-4 |
| [44] | Thoren, F., Johnsson, A.A., Brandberg, J., et al. (2019) CT Co-lonography: Implementation, Indications, and Technical Performance—A Follow-Up National Survey. Acta Radiologica, 60, 271-277.
https://doi.org/10.1177/0284185118780899 |
| [45] | Done, J. and Fang, S.H. (2021) Young-Onset Colorectal Cancer: A Review. World Journal of Gastrointestinal Oncology, 13, 856-866. https://doi.org/10.4251/wjgo.v13.i8.856 |
